PTC Therapeutics
PTCT
#3035
Rank
โ‚ฌ4.81 B
Marketcap
57,63ย โ‚ฌ
Share price
0.21%
Change (1 day)
-11.37%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): -1,11ย โ‚ฌ

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,19ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 7,98ย โ‚ฌ an increase over its 2024 EPS that were of -4,29ย โ‚ฌ.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,11ย โ‚ฌ-113.91%
20257,98ย โ‚ฌ-285.84%
2024-4,29ย โ‚ฌ
2022-7,07ย โ‚ฌ4.85%
2021-6,74ย โ‚ฌ
2019-4,06ย โ‚ฌ66.17%
2018-2,44ย โ‚ฌ29.33%
2017-1,89ย โ‚ฌ-50.12%
2016-3,79ย โ‚ฌ-17.59%
2015-4,59ย โ‚ฌ57.63%
2014-2,91ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,77ย โ‚ฌ-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
14,22ย โ‚ฌ-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,43ย โ‚ฌ 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-2,39ย โ‚ฌ 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-0,95ย โ‚ฌ-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-3,79ย โ‚ฌ 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA